focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,787.00
Bid: 1,786.50
Ask: 1,787.50
Change: -25.50 (-1.41%)
Spread: 1.00 (0.056%)
Open: 1,792.50
High: 1,802.00
Low: 1,787.00
Prev. Close: 1,812.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TOP NEWS: UK Manufacturing Expands As Mortgage Approvals Shrink

Mon, 02nd Jun 2014 09:50

LONDON (Alliance News) - The following is a summary of top news stories Monday.
----------
COMPANIES
----------
Lloyds Banking Group PLC has given TSB GBP450 million as part of its stock market floatation, the Daily Telegraph reported on Saturday, citing documents sent to investors. Lloyds, which is spinning off TBS in a stock market listing to satisfy European Commission requirements, will pay up to GBP450 million in the case that TSB wants to change its technology platform or if it is taken over, the paper says. The newspaper cited sources saying that the dowry could be viewed as a potential sweetener for any would-be buyer of the new bank.
----------
GlaxoSmithKline PLC has completed a deal to develop new cancer drugs with a UK biotech company, which could be worth over USD350 million, the Financial Times reports Monday, quoting Adaptimmune Ltd Chief Executive James Noble. Glaxo is expected to announce a deal on Monday in which it will pay Adaptimmune the cash over the next seven years, subject to certain development milestones being met, the FT says. The companies will work together to develop cell-based cancer therapies that involve re-engineering white blood cells to strengthen the body's ability to fight tumours.
----------
Shire PLC has secured a USD5 billion credit facility from banks including Citigroup to finance its planned takeover offer for the US's NPS Pharmaceuticals, The Times said on Monday, citing insiders. The FTSE 100 listed pharmaceutical company is believed to have arranged the deal to buttress its takeover offer for NPS, a developer of drugs for sufferers of a debilitating bowel condition.
----------
St Modwen Properties PLC said it still expects to report pretax profit for the first half of its financial year significantly up on the year-earlier period, after it continued to perform "strongly" over the past two months. In a statement, the property company said it expects its asset management and added value activities to be reflected positively in half-year valuations, while initial indications point to a rise in market valuations for the first half of the year compared with November 2013, reflecting improvements in the residential and commercial property markets across the UK.
----------
Infrastructure company Balfour Beatty PLC said it had sold its interests in two public-private partnership assets for GBP97 million in total, generating total gains on disposal of GBP51 million. In a statement, the company said it had sold its 50% interest in the University Hospital of North Durham PPP project and its 100% interest in the Knowsley Building Schools for the Future project, with both assets bought by Dalmore Capital Ltd.
----------
MARKETS
----------
The UK's leading stock index is trading higher, with the mining sector leading the gains after an improved Chinese manufacturing PMI was released on Sunday, while the picture in Europe is more mixed as Markit PMI readings released across the region Monday have been broadly disappointing.
----------
FTSE 100: up 0.3% at 6,862.18
FTSE 250: up 0.6% at 16,097.82
AIM ALL-SHARE: flat at 815.40
----------
Both the pound and the euro have weakened a little against the dollar.
----------
GBP-USD: down at USD1.6744
EUR-USD: down at USD1.3599

GOLD: down at USD1,244.80 per ounce
OIL (Brent): up at USD109.56 a barrel

(changes since end of previous GMT day)
----------
ECONOMICS AND GENERAL
----------
British manufacturing activity continued robust expansion in May, led by strong growth in output, new orders and new export business, survey data from the Markit Economics and the Chartered Institute of Purchasing & Supply showed. The Markit/CIPS Purchasing Managers' Index eased to 57 from April's five-month high of 57.3. A PMI score above 50 suggest expansion in the sector. The sector has grown every month since March last year.
----------
UK mortgage approvals declined to the the lowest since July 2013, data from the Bank of England showed. Approvals fell more-than-expected to 62,918 in April, a nine-month low, from 66,563 in March. The expected level was 64,500. Lending secured on dwellings increased GBP 1.7 billion from March, when it was up GBP 1.8 billion. At the same time, consumer credit rose GBP 0.7 billion compared to March's GBP 1 billion increase. M4 money supply declined further in May, down 0.6% annually compared to a 0.3% drop in March.
----------
Plans to allow workers to contribute to Dutch-style collective pensions are to be unveiled by the government and are expected to feature in a Pensions Bill to be announced in the Queen's Speech on Wednesday, the BBC reports Monday without saying where it got the information. By running funds collectively rather than individually, supporters argue costs will be lower and therefore pension incomes will be higher. Ministers say the move will give people "better value", but critics argue the returns are not certain, the BBC says. Under the changes, which could be introduced by 2016 the BBC says, workers would be able to pay into funds shared with potentially thousands of other members.
----------
The recovery in the Eurozone manufacturing sector was slower than initially estimated in May, final data from Markit Economics showed. The final seasonally adjusted Markit manufacturing Purchasing Managers' Index fell to 52.2 from 53.4 in April. The flash estimate for May was 52.5.
----------
Showing signs of a stabilizing economy, China's manufacturing sector growth accelerated in May to its highest level this year, data from the National Bureau of Statistics and the China Federation of Logistics and Purchasing showed Sunday. China's purchasing managers' index for May improved to 50.8 from 50.4 in April, showing signs of a pickup in the manufacturing sector and the economy -- the third consecutive monthly growth. The index, a key indicator of how the economy performs, has been on the rise since March after three straight months of decline.
----------
Ukraine has paid the first instalment in a series of payments for Russian gas, Moscow confirmed, potentially blunting one of the lingering points of tension between the two countries. Ukrainian supplier Naftogas disbursed USD786.4 million to pay off its gas debt, reported the Russian Energy Ministry, as quoted by the Interfax news agency. Russia says Ukraine's total gas debt amounts to USD5.2 billion and has threatened to stop the flow of gas if no payment is made. Renewed negotiations are expected later Monday in Brussels.
----------
Jean-Claude Juncker said in interview published Sunday that he is confident he will become the next president of the European Commission, despite British Prime Minister David Cameron reportedly warning it could lead to his country's exit from the bloc. "Europe should not be blackmailed," the former conservative primer minister of Luxembourg told the Bild am Sonntag newspaper. Juncker added that he had "large support" from EU leaders - both conservative and socialist - to assume the top spot in the European Commission, the 28-member union's executive arm, and that he could be in the position by mid-July.
----------
Portuguese Prime Minister Pedro Passos Coelho said Saturday the country faces a tough road ahead after its top court once again blew a hole in the government's budget by declaring cost-cutting efforts unconstitutional. "It will not be easy to find a way out of this," said Passos Coelho. "The government will not be rushed into a decision." However, he said his administration would respect the ruling, keep Portugal from descending into crisis and find a solution that did not require asking EU allies for aid. But he said he was "deeply concerned." The Friday ruling by Portugal's top court said that about EUR1 billion in benefit cuts for public employees would be discriminatory and, therefore, unlawful.
----------
The Afghan government voiced opposition to the release of five high-level Taliban members from Guantanamo Bay detention camp this weekend, saying that sending them to Qatar could be against international law. The US government on Saturday freed five senior figures in the Taliban after they had spent 13 years in custody, in exchange for US Army Sergeant Bowe Bergdahl, who was captured by the Taliban in June 2009.
----------
At least 60 people were killed Sunday when Islamist extremist sect Boko Haram bombed a bar and brothel near a major military base in northern Nigeria, according to local newspaper Sahara Reporters. A major explosion rocked two buildings in the town of Mubi in Adamawa State at 1700 GMT, in close proximity to a special operations battalion of Nigeria's army, which is focused on fighting Boko Haram, security officials said.
----------
The US government will introduce new regulations aimed at reducing greenhouse gas emissions by a third by 2030, according to media reports Sunday. At the order of President Barack Obama, the US Environmental Protection Agency will lay out a plan Monday that envisions power plants releasing 30% less carbon dioxide into the atmosphere in 16 years than they did in 2005. The new regulations would go in effect in a year.
----------
Copyright 2014 Alliance News Limited. All Rights Reserved.


More News
20 Dec 2023 13:29

GSK buys rights to Hansoh Pharma antibody-drug conjugate

(Sharecast News) - GSK has agreed to buy the rights to an antibody-drug conjugate (ADC) - HS-20093 - from Chinese biopharmaceutical group Hansoh Pharma.

Read more
19 Dec 2023 15:36

German court quashes CureVac patent after challenge by BioNTech

CureVac shares drop 40%Dispute over intellectual property with BioNTech to continue

*

Read more
18 Dec 2023 17:21

Energy stocks lift UK's FTSE 100, Vodafone shines

Vodafone jumps as Iliad offers to merge Italian units

*

Read more
18 Dec 2023 10:07

GSK's dostarlimab trial in endometrial cancer meets primary endpoint

(Alliance News) - GSK PLC on Monday said a trial of dostarlimab in combination with niraparib for treating endometrial cancer has met its primary endpoint.

Read more
18 Dec 2023 07:55

LONDON BRIEFING: Games Workshop seals Amazon deal for Warhammer 40,000

(Alliance News) - Stocks in London were set to retreat slightly on Monday, in line with equity markets in Asia, at the start of the last week before the Christmas holidays.

Read more
18 Dec 2023 07:18

GSK sees success in Jemperli endometrial cancer trial

(Sharecast News) - GSK released positive headline results from the planned analysis of its trial of Jemperli in endometrial cancer on Monday.

Read more
17 Dec 2023 15:16

PRESS: GSK looks for deals in China as rebuilds relationship

(Alliance News) - The Financial Times on Sunday reported that GSK PLC is looking for some new deals in China.

Read more
15 Dec 2023 17:08

European shares end fifth week higher on rate-cut optimism

Barclays sees first ECB rate cut in April

*

Read more
15 Dec 2023 16:51

LONDON MARKET CLOSE: FTSE 100 underperforms as post-Fed rally cools

(Alliance News) - London's FTSE 100 ended lower on Friday, with profit-taking and some hawkish words from a US policymaker keeping equities in check at the end of a largely positive week for stocks.

Read more
15 Dec 2023 16:29

PRESS: GSK, Astra and AbbVie in US scrutiny over patents - Bloomberg

(Alliance News) - A US senator has accused AstraZeneca PLC, GSK PLC, AbbVie Inc and other drugmakers of "abusing" the patent system to send prices higher, Bloomberg reported on Thursday.

Read more
12 Dec 2023 10:08

AstraZeneca buys respiratory vaccine developer Icosavax in $1.1 bln deal

Dec 12 (Reuters) - AstraZeneca said on Tuesday it had agreed to buy respiratory syncytial virus (RSV) vaccine developer Icosavax in a deal valued at up to $1.1 billion.

Read more
12 Dec 2023 08:22

TOP NEWS: Japan accepts GSK's filing for respiratory disease vaccine

(Alliance News) - GSK PLC on Tuesday said Japan's Ministry of Health, Labour & Welfare has accepted its regulatory application for the extension of its respiratory syncytial virus vaccine, Arexvy, for adults aged 50-59.

Read more
12 Dec 2023 07:39

LONDON BRIEFING: UK unemployment unchanged at 4.2%; eyes on US CPI

(Alliance News) - Stocks in London are called to open higher, as investors digest the latest UK unemployment data, before turning their heads to US inflation.

Read more
12 Dec 2023 07:24

GSK seeks to extend RSV vaccine approval in Japan

(Sharecast News) - GSK announced on Tuesday that Japan's Ministry of Health, Labour and Welfare (MHLW) has accepted its regulatory application for the extension of the indication of its RSV vaccine to include adults aged 50- to 59 at an increased risk of contracting the disease.

Read more
11 Dec 2023 08:28

GSK drug gets EU marketing backing for form of endometrial cancer

(Alliance News) - GSK PLC on Monday said it won EU backing for its Jemperli drug in tandem with chemotherapy to treat a form of endometrial cancer.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.